Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Thorne Healthtech stock price, quote, forecast and news

THRN
US8852601090

Price

10.19
Today +/-
+0
Today %
+0 %
P

Thorne Healthtech stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Thorne Healthtech stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Thorne Healthtech stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Thorne Healthtech stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Thorne Healthtech's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Thorne Healthtech Stock Price History

DateThorne Healthtech Price
10/16/202310.19 undefined
10/13/202310.19 undefined

Thorne Healthtech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Thorne Healthtech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Thorne Healthtech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Thorne Healthtech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Thorne Healthtech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Thorne Healthtech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Thorne Healthtech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Thorne Healthtech’s growth potential.

Thorne Healthtech Revenue, EBIT and net profit per share

DateThorne Healthtech RevenueThorne Healthtech EBITThorne Healthtech Net Income
2025e430.37 M undefined67.02 M undefined58.43 M undefined
2024e368.07 M undefined48.16 M undefined33.62 M undefined
2023e294.11 M undefined23.83 M undefined17.91 M undefined
2022228.73 M undefined5.48 M undefined15.67 M undefined
2021184.3 M undefined11.32 M undefined3.75 M undefined
2020138.45 M undefined1.01 M undefined-3.36 M undefined
2019102.53 M undefined-13.91 M undefined-21.54 M undefined

Thorne Healthtech Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20192020202120222023e2024e2025e
102138184228294368430
-35.2933.3323.9128.9525.1716.85
43.1446.3852.1750.00---
446496114000
-131115234867
-12.750.725.982.197.8213.0415.58
-21-3315173358
--85.71-200.00400.0013.3394.1275.76
0.10.152.5552.76000
-------
Details

Keystats

ⓘ

Revenue and Growth

The Thorne Healthtech Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Thorne Healthtech is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2019202020212022
       
0.4615.2651.136.02
4.952.515.6514.44
0000
27.7328.0741.0158.64
0.760.893.497.52
33.9146.73101.26116.62
38.9341.745.7569.87
4.684.531.362.34
000153.56
8.577.646.5911.83
14.4414.4414.4420.04
0.470.455.898.95
67.0968.7674.04113.18
101.01115.49175.3229.8
       
133.48133.610.530.53
28.5452.45250.16260.98
-129.61-132.96-132.16-116.48
000-0.03
0000
32.4253.1118.53145
6.698.6916.8927
3.196.436.38.11
17.77000.46
4.810.811.631.8
0.080.490.912.18
32.5416.4225.7439.56
11.3420.921.5714.1
0000
30.5631.529.6629.49
41.952.4231.2343.59
74.4468.8456.9783.15
106.86121.94175.5228.15
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Thorne Healthtech provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Thorne Healthtech's financial health and stability.

Assets

Thorne Healthtech's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Thorne Healthtech must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Thorne Healthtech after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Thorne Healthtech's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2019202020212022
-18-3614
4445
000-7
-12-2-16-20
30291824
01,00000
0000
-71795
-2-2-5-17
-4-3-7-33
-1-1-2-15
0000
115-2111
00700
1113813
00-92
0-300
01440-15
-10.5314.784.02-12.64
0000

Thorne Healthtech stock margins

The Thorne Healthtech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thorne Healthtech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thorne Healthtech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Thorne Healthtech's sales revenue. A higher gross margin percentage indicates that the Thorne Healthtech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Thorne Healthtech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Thorne Healthtech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Thorne Healthtech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Thorne Healthtech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Thorne Healthtech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Thorne Healthtech Margin History

Thorne Healthtech Gross marginThorne Healthtech Profit marginThorne Healthtech EBIT marginThorne Healthtech Profit margin
2025e50.25 %15.57 %13.58 %
2024e50.25 %13.08 %9.14 %
2023e50.25 %8.1 %6.09 %
202250.25 %2.4 %6.85 %
202152.31 %6.14 %2.03 %
202046.79 %0.73 %-2.43 %
201943.64 %-13.56 %-21.01 %

Thorne Healthtech Stock Sales Revenue, EBIT, Earnings per Share

The Thorne Healthtech earnings per share therefore indicates how much revenue Thorne Healthtech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thorne Healthtech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thorne Healthtech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thorne Healthtech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thorne Healthtech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thorne Healthtech Revenue, EBIT and net profit per share

DateThorne Healthtech Sales per ShareThorne Healthtech EBIT per shareThorne Healthtech Earnings per Share
2025e7.96 undefined0 undefined1.08 undefined
2024e6.81 undefined0 undefined0.62 undefined
2023e5.44 undefined0 undefined0.33 undefined
20224.34 undefined0.1 undefined0.3 undefined
20213.51 undefined0.22 undefined0.07 undefined
20201,353.69 undefined9.92 undefined-32.83 undefined
20191,002.47 undefined-135.96 undefined-210.57 undefined

Thorne Healthtech business model

Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements. The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements. Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts. The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength. Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements. Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C. A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more. In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech is one of the most popular companies on Eulerpool.com.

Thorne Healthtech SWOT Analysis

Strengths

Thorne Healthtech Inc. possesses strong brand recognition and reputation in the healthtech industry. The company has a diverse portfolio of innovative products and services, contributing to its market leadership. Thorne also has a highly skilled and experienced workforce, enabling them to develop high-quality and cutting-edge solutions. Additionally, the company benefits from strong financial stability and strategic partnerships, enhancing its competitive advantage.

Weaknesses

One of Thorne Healthtech Inc.'s weaknesses is its limited geographical presence, primarily focusing on specific regions or markets. This can hinder the company's growth potential and market expansion opportunities. Another weakness is its reliance on third-party suppliers for raw materials and components, which could lead to potential supply chain disruptions or quality control issues.

Opportunities

The healthtech industry is experiencing significant growth worldwide, providing Thorne Healthtech Inc. with ample opportunities for market expansion. By leveraging their expertise and reputation, Thorne can further penetrate emerging markets and capitalize on the rising demand for innovative healthcare solutions. The increasing adoption of digital health technologies and telemedicine also opens doors for Thorne to develop and offer new tech-based solutions.

Threats

Thorne Healthtech Inc. faces intense competition from existing players and new entrants in the healthtech sector. This may lead to price wars, margin erosion, or loss of market share if not adequately addressed. Regulatory changes and evolving legal frameworks for healthcare products and services can also present challenges for the company, requiring continuous adaptation and compliance efforts. Additionally, economic uncertainties and fluctuations in exchange rates could impact Thorne's financial performance and international operations.

Thorne Healthtech Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Thorne Healthtech historical P/E ratio, EBIT, and P/S ratio.

Thorne Healthtech shares outstanding

The number of shares was Thorne Healthtech in 2023 — This indicates how many shares 52.758 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thorne Healthtech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thorne Healthtech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thorne Healthtech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thorne Healthtech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Thorne Healthtech.

Thorne Healthtech latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20230.06 0.08  (30.72 %)2023 Q2
3/31/20230.08 -0.01  (-112.25 %)2023 Q1
12/31/20220.18 0.24  (30.72 %)2022 Q4
9/30/20220.14 0.07  (-50.98 %)2022 Q3
6/30/2022-0.01 -0.11  (-2,056.86 %)2022 Q2
3/31/20220.1 0.09  (-8.72 %)2022 Q1
12/31/20210.03 0.06  (96.08 %)2021 Q4
9/30/2021-0.03 0.01  (130.12 %)2021 Q3
1

Thorne Healthtech list of shareholders

%
Name
Stocks
Change
Date
3.32629 % Emerald Advisers LLC1,797,528-93,8376/30/2023
2.96529 % Diversified Natural Products Inc1,602,44504/21/2023
10.03803 % Helsinn International (U.S.) Corporation5,424,55004/21/2023
1.56898 % The Vanguard Group, Inc.847,875-9,8906/30/2023
1.09346 % BlackRock Institutional Trust Company, N.A.590,90879,3076/30/2023
0.91175 % Jacobson (Paul F)492,709-220,3776/29/2023
0.52406 % Cresset Asset Management, LLC283,203283,2036/30/2023
0.46253 % Geode Capital Management, L.L.C.249,9525,3846/30/2023
0.41111 % Conley (Bryan K.)222,162-7,83812/1/2022
0.39370 % McKenna (Thomas P)212,757-297,0014/21/2023
1
2
3
4
5
...
10

Thorne Healthtech Executives and Management Board

Mr. Paul Jacobson69
Thorne Healthtech Chairman of the Board, Chief Executive Officer, Co-Founder (since 2023)
Compensation 4.09 M
Mr. Thomas Mckenna63
Thorne Healthtech Chief Operating Officer, Director (since 2010)
Compensation 2.89 M
Mr. William Mccamy54
Thorne Healthtech President
Compensation 1.35 M
Ms. Sarah Kauss47
Thorne Healthtech Independent Director
Compensation 469,445
Ms. Saloni Varma43
Thorne Healthtech Chief Financial Officer, Director (since 2021)
Compensation 463,195
1
2

Thorne Healthtech Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Amazon.com Stock
Amazon.com
SupplierCustomer0,820,810,220,21--
Sumitomo Pharma Stock
Sumitomo Pharma
SupplierCustomer0,810,370,080,02--
Mitsui & Co Stock
Mitsui & Co
SupplierCustomer0,44-0,030,470,18--
Kirin Holdings Stock
Kirin Holdings
SupplierCustomer0,25-0,43-0,03-0,25--
Unilever Stock
Unilever
SupplierCustomer-0,26-0,61-0,84-0,45--
Endeavor Group Holdings A Stock
Endeavor Group Holdings A
SupplierCustomer-0,690,22-0,21-0,25--
Quest Diagnostics Stock
Quest Diagnostics
SupplierCustomer-0,77-0,66-0,220,25--
1

Most common questions regarding Thorne Healthtech

What values and corporate philosophy does Thorne Healthtech represent?

Thorne Healthtech Inc represents values of innovation, quality, and excellence in the field of health technology. The company's corporate philosophy revolves around improving the well-being of individuals through cutting-edge solutions and nutritional support. Thorne Healthtech Inc prioritizes research and development, ensuring that their products are backed by rigorous scientific evidence. With a strong commitment to providing safe and effective health products, Thorne Healthtech Inc has gained a reputable position in the industry. Their dedication to high standards and customer satisfaction drives their mission of enhancing lives through advanced health technologies.

In which countries and regions is Thorne Healthtech primarily present?

Thorne Healthtech Inc is primarily present in the United States, Canada, Europe, and Asia. With a strong global presence, the company has established a significant market share in these regions. Thorne Healthtech Inc's dedication to expanding its reach beyond borders has allowed it to tap into diverse customer bases and explore new growth opportunities. With a focus on delivering innovative health technology solutions, Thorne Healthtech Inc continues to make its mark in healthcare markets worldwide.

What significant milestones has the company Thorne Healthtech achieved?

Thorne Healthtech Inc has achieved several significant milestones in their journey. They have successfully expanded their product offerings, gained a strong customer base, and established themselves as a leading player in the healthcare technology industry. Thorne Healthtech Inc has also made notable advancements in research and development, resulting in innovative solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has further solidified its market position and global presence. Thorne Healthtech Inc continues to deliver exceptional products and services, shaping the future of healthcare technology with their unwavering commitment to excellence and innovation.

What is the history and background of the company Thorne Healthtech?

Thorne Healthtech Inc., a renowned company in the healthcare industry, has an impressive history and background. Founded in [insert year], Thorne Healthtech Inc. has been providing innovative solutions and high-quality products to improve people's well-being. With a strong focus on research and development, the company has become a leader in the market, offering a wide range of healthcare products and services. Thorne Healthtech Inc. has continuously evolved over the years, expanding its reach both nationally and internationally. Known for its commitment to excellence, Thorne Healthtech Inc. remains dedicated to enhancing the health and vitality of individuals worldwide.

Who are the main competitors of Thorne Healthtech in the market?

The main competitors of Thorne Healthtech Inc in the market are leading healthcare companies such as Johnson & Johnson, Pfizer, and Roche. These established companies have a strong presence and offer similar products and services in the healthcare industry. Thorne Healthtech Inc competes by differentiating itself through innovative and high-quality health products, holistic approaches, and a focus on natural remedies. With its unique offerings and customer-centric approach, Thorne Healthtech Inc aims to carve a niche for itself in the competitive market landscape.

In which industries is Thorne Healthtech primarily active?

Thorne Healthtech Inc is primarily active in the healthcare and technology industries.

What is the business model of Thorne Healthtech?

Thorne Healthtech Inc operates under a business model focused on improving health and wellness through the development and distribution of high-quality nutritional supplements and personalized health solutions. The company aims to provide scientifically-backed products that support various aspects of health, including immune function, stress management, athletic performance, and more. Thorne Healthtech Inc prioritizes research and innovation to create safe and effective products that meet the ever-evolving health needs of individuals. By leveraging their expertise in nutritional science, Thorne Healthtech Inc strives to empower individuals to take control of their health and enhance their overall well-being.

What is the P/E ratio of Thorne Healthtech 2024?

The Thorne Healthtech P/E ratio is 15.99.

What is the P/S ratio of Thorne Healthtech 2024?

The Thorne Healthtech P/S ratio is 1.46.

What is the AlleAktien quality score of Thorne Healthtech?

The AlleAktien quality score for Thorne Healthtech is 3/10.

What is the revenue of Thorne Healthtech 2024?

The expected Thorne Healthtech revenue is 368.07 M USD.

How high is the profit of Thorne Healthtech 2024?

The expected Thorne Healthtech profit is 33.62 M USD.

What is the business model of Thorne Healthtech

Thorne Healthtech Inc is a company specialized in the development and marketing of high-quality dietary supplements. The company is based in the USA and has been operating in the industry for over 30 years. With a focus on scientifically backed products and a dedicated team of experts, Thorne Healthtech Inc has developed a business model that focuses on offering high-quality products tailored to the needs of athletes, medical professionals, and consumers. The company has various divisions that cater to the needs of different target groups. The first division is sports nutrition, offering a wide range of products designed for athletes of all performance levels. These range from protein powders and carbohydrate supplements to products tailored to the needs of athletes before, during, and after training. Another important division of the company is medical nutrition, offering products tailored to the needs of patients suffering from conditions such as diabetes, liver disease, or gastrointestinal problems. These products have been developed to alleviate the symptoms of the conditions and improve the health of patients. Another division is animal nutrition. Thorne Healthtech Inc has developed a wide range of products tailored to the needs of dogs and cats. These products include supplements that support digestion and joint health, as well as products aimed at improving the well-being of animals. Another important area of Thorne Healthtech Inc is women's and men's health, offering products tailored to the needs of women and men, such as dietary supplements that help balance hormones or enhance libido. The company also offers a wide range of products focused on general health and well-being. These include products like multivitamin supplements that complement daily nutrition and are tailored to the needs of people of all ages. The business model of Thorne Healthtech Inc is based on scientifically backed products developed by a dedicated team of experts. The company collaborates with leading research institutions and medical professionals to ensure that its products meet the highest quality standards. Furthermore, the company only uses the best available ingredients and ensures that all products are manufactured in facilities that meet the highest quality standards. The company distributes its products both online and through a network of distribution partners and medical professionals. This allows Thorne Healthtech Inc to reach a wide range of customers, including athletes, medical professionals, and consumers in search of high-quality dietary supplements. Overall, the business model of Thorne Healthtech Inc aims to offer high-quality products tailored to the needs of different target groups. With a strong focus on research and development, the company has developed a wide range of products that cater to the needs of athletes, medical professionals, and consumers.

What is the Thorne Healthtech dividend?

Thorne Healthtech pays a dividend of 0 USD distributed over payouts per year.

How often does Thorne Healthtech pay dividends?

The dividend cannot currently be calculated for Thorne Healthtech or the company does not pay out a dividend.

What is the Thorne Healthtech ISIN?

The ISIN of Thorne Healthtech is US8852601090.

What is the Thorne Healthtech ticker?

The ticker of Thorne Healthtech is THRN.

How much dividend does Thorne Healthtech pay?

Over the past 12 months, Thorne Healthtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Thorne Healthtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Thorne Healthtech?

The current dividend yield of Thorne Healthtech is .

When does Thorne Healthtech pay dividends?

Thorne Healthtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Thorne Healthtech?

Thorne Healthtech paid dividends every year for the past 0 years.

What is the dividend of Thorne Healthtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Thorne Healthtech located?

Thorne Healthtech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Thorne Healthtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Thorne Healthtech from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Thorne Healthtech pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Thorne Healthtech in the year 2023?

In the year 2023, Thorne Healthtech distributed 0 USD as dividends.

In which currency does Thorne Healthtech pay out the dividend?

The dividends of Thorne Healthtech are distributed in USD.

All fundamentals about Thorne Healthtech

Our stock analysis for Thorne Healthtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thorne Healthtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.